Literature DB >> 31761473

Oligometastatic non-small cell lung cancer (NSCLC): Does number of metastasis matter?

Niccolò Giaj-Levra1, Matteo Giaj Levra2, Thierry Berghmans3, Silvia Novello4, Lizza E Hendriks5, Antonin Levy6, Benjamin Besse7, Anne-Marie C Dingemans8.   

Abstract

Entities:  

Year:  2019        PMID： 31761473     DOI： 10.1016/j.lungcan.2019.11.005

Source DB:  PubMed          Journal:  Lung Cancer        ISSN： 0169-5002            Impact factor:   5.705


× No keyword cloud information.
  4 in total

Review 1.  Narrative review: molecular and genetic profiling of oligometastatic non-small cell lung cancer.

Authors:  Sawsan Rashdan; Puneeth Iyengar; John D Minna; David E Gerber
Journal:  Transl Lung Cancer Res       Date:  2021-07

Review 2.  Defining oligometastatic non-small cell lung cancer: concept versus biology, a literature review.

Authors:  Jill F Mentink; Marthe S Paats; Daphne W Dumoulin; Robin Cornelissen; Joris B W Elbers; Alexander P W M Maat; Jan H von der Thüsen; Anne-Marie C Dingemans
Journal:  Transl Lung Cancer Res       Date:  2021-07

3.  Surgical Survival Benefits With Different Metastatic Patterns for Stage IV Extrathoracic Metastatic Non-Small Cell Lung Cancer: A SEER-Based Study.

Authors:  Ce Chao; Yongxiang Qian; Xihao Li; Chen Sang; Bin Wang; Xiao-Ying Zhang
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

4.  Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised controlled open-label phase II trial.

Authors:  Relinde I Y Lieverse; Evert J Van Limbergen; Cary J G Oberije; Esther G C Troost; Sine R Hadrup; Anne-Marie C Dingemans; Lizza E L Hendriks; Franziska Eckert; Crispin Hiley; Christophe Dooms; Yolande Lievens; Monique C de Jong; Johan Bussink; Xavier Geets; Vincenzo Valentini; Giuliano Elia; Dario Neri; Charlotte Billiet; Amir Abdollahi; David Pasquier; Pierre Boisselier; Ala Yaromina; Dirk De Ruysscher; Ludwig J Dubois; Philippe Lambin
Journal:  BMC Cancer       Date:  2020-06-15       Impact factor: 4.430
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.